Colorectal Cancer Clinical Trial
Official title:
Implementing a Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity
Verified date | May 2023 |
Source | Washington University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, and ultimately reduce cancer patients' financial toxicity associated with cancer care.
Status | Completed |
Enrollment | 150 |
Est. completion date | November 4, 2021 |
Est. primary completion date | August 27, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Eligibility criteria for I Can Pic Arm only: Inclusion Criteria: - 18 years of age or older - Must have been diagnosed with colorectal cancer, lung cancer, or gynecologic cancer < 5 months ago and be patients of one of the 15 providers - This cancer diagnosis must be the first and primary diagnosis Exclusion Criteria: - Not able to read and understand English - Cannot give informed consent due to cognitive or emotional barriers |
Country | Name | City | State |
---|---|---|---|
United States | Washington University School of Medicine | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Washington University School of Medicine | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Delayed or Forgone Care Due to Costs (I Can PIC Arm) | Delayed or forgone care due to costs will be collected on the post-intervention survey and the 3-6 month follow-up survey
Score from 0 (best) to 8 (worst). Higher scores indicate more frequent delayed and forgone care due to costs |
Change from post-intervention survey to 3-6 month follow-up survey (estimated to be a total of 6 months) | |
Other | Delayed or Forgone Care Due to Costs (Historical Control Arm and I Can PIC Arm) | Delayed or forgone care due to costs will be collected on the historical control survey and the I Can PIC post-intervention survey
Score from 0 (best) to 8 (worst). Higher scores indicate more frequent delayed and forgone care due to costs |
Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in Health Insurance Knowledge Between Historical Control Arm and I Can PIC Arm | Health insurance knowledge will be collected on the historical control survey and the I Can PIC post-intervention survey
Score from 0% (worst) to 100% (best). Higher scores indicate greater health insurance knowledge |
Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in Health Insurance Literacy Between Historical Control Arm and I Can PIC Arm | Health insurance literacy will be collected on the historical control survey and the I Can PIC post-intervention survey
Score from 12 (worst) to 48 (best). Higher scores indicate greater health insurance literacy |
Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in the Number of Clinicians That Discussed Health Care Cost Topics With Participants Between the Historical Control Arm and I Can PIC Arm | Information regarding clinicians who discussed health care costs will be collected on the historical control survey and the I Can PIC post-intervention survey
Score either no (did not discuss health care costs with clinician) or yes (discussed one more cost-related topics with clinicians) Also score the number of cost-related topics discussed, if yes |
Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in the Number of Cost-related Topics Discussed With Participants Between the Historical Control Arm and I Can PIC Arm | -Information regarding clinicians who discussed health care costs will be collected on the historical control survey and the I Can PIC post-intervention survey | Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in the Number of Clinicians That Discussed Health Care Cost Strategies Between the Historical Control Arm and I Can PIC Arm | -Information regarding clinicians who discussed health care costs will be collected on the historical control survey and the I Can PIC post-intervention survey | Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in the Number of Cost Strategies Discussed Between the Historical Control Arm and I Can PIC Arm | -Information regarding clinicians who discussed health care costs will be collected on the historical control survey and the I Can PIC post-intervention survey | Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in Confidence Communicating About Health Care Costs With Physician Between Historical Control Arm and I Can PIC Arm | Confidence communicating about health care costs will be collected on the historical control survey and the I Can PIC post-intervention survey
Score from 4 (worst) to 16 (best). Higher scores indicate greater confidence communicating about care costs |
Completion of survey (estimated to be approximately 1-14 days after enrollment) | |
Primary | Difference in Financial Toxicity Between Historical Control Arm and I Can PIC Arm | Financial toxicity will be collected on the historical control survey and the I Can PIC post-intervention survey
Score from 0 (best) to 44 (worst). Higher scores indicate greater financial toxicity |
Completion of survey (estimated to be Day 1 for historical control participants and estimated to be Day 14 for I Can PIC participants) | |
Primary | Difference in Number of Clinicians Who Referred Patients to Resources to Discuss Costs | Information regarding clinicians who discussed health care costs will be collected on the historical control survey and the I Can PIC post-intervention survey
Score either no (did not refer to resources) or yes (referred to resources) Also score the number of cost-related topics discussed, if yes |
Completion of survey (estimated to be approximately 1-14 days after enrollment)] | |
Secondary | Health Insurance Knowledge Sustained Over Time (I Can PIC Arm) | Sustained Health insurance knowledge will be collected on the post-intervention survey and the 3-6 month follow-up survey
Score from 0% (worst) to 100% (best). Higher scores indicate greater health insurance knowledge |
Change from post-intervention survey to 3-6 month follow-up survey (estimated to be a total of 6 months) | |
Secondary | Health Insurance Literacy Sustained Over Time (I Can PIC Arm) | Sustained Health insurance literacy will be collected on the post-intervention survey and the 3-6 month follow-up survey
Score from 12 (worst) to 48 (best). Higher scores indicate greater health insurance literacy |
Change from post-intervention survey to 3-6 month follow-up survey (estimated to be a total of 6 months) | |
Secondary | Confidence Communicating About Health Care Costs With Physician (I Can PIC Arm) | Confidence communicating about health care costs will be collected on the post-intervention survey and the 3-6 month follow-up survey
Score from 4 (worst) to 16 (best). Higher scores indicate greater confidence communicating about care costs |
Change from post-intervention survey to 3-6 month follow-up survey (estimated to be a total of 6 months) | |
Secondary | Sustained Financial Toxicity (I Can PIC Arm) | Sustained Financial toxicity will be collected on the post-intervention survey and the 3-6 month follow-up survey
Score from 0 (best) to 44 (worst). Higher scores indicate greater financial toxicity |
Change from post-intervention survey to 3-6 month follow-up survey (estimated to be a total of 6 months) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |